[Effects of MSCs on the progression of atherosclerosis plaque in ApoE-knock out mice]

Zhi-xiao Wang1, Shan Mao, Yu Li

  • 1Department of Cardiology, Hubei University of Medicine, Shiyan, China.

Abstract

Insights

Mesenchymal stem cells (MSCs) significantly reduced atherosclerosis plaque size in mice. MSCs also modulated immune responses, increasing regulatory T cells and anti-inflammatory cytokines, suggesting a therapeutic role in atherosclerosis.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • Atherosclerosis is a chronic inflammatory disease.
  • Hypercholesterolemia accelerates atherosclerosis plaque formation.
  • Mesenchymal stem cells (MSCs) possess immunomodulatory properties.

Purpose of the Study:

  • To investigate the therapeutic potential of MSCs in inhibiting atherosclerosis.
  • To analyze the impact of MSCs on plaque size and immune cell populations in hypercholesterolemic mice.

Main Methods:

  • Atherosclerosis was induced in apolipoprotein E knockout (ApoE-/-) mice.
  • Mesenchymal stem cells (MSCs) were administered intravenously.
  • Atherosclerotic plaque area, regulatory T cell (Treg) percentages, splenocyte proliferation, and cytokine levels were assessed.

Main Results:

  • MSC treatment significantly reduced atherosclerotic plaque size compared to controls.
  • MSC administration increased the percentage of CD4+CD25+ regulatory T cells in the spleen.
  • MSCs modulated cytokine profiles, increasing TGF-β and IL-10, and decreasing IFN-γ.

Conclusions:

  • MSCs play a crucial role in regulating inflammatory responses.
  • MSC therapy demonstrates significant potential in inhibiting atherosclerosis plaque formation in ApoE-/- mice.